Please login to the form below

Fasenra

This page shows the latest Fasenra news and features for those working in and with pharma, biotech and healthcare.

medicines such as Imfinzi and monoclonal antibody Fasenra (benralizumab).

AZ, Amgen’s investigational asthma drug comes good in phase 3

AZ’s own interleukin-5 inhibitor (IL-5) Fasenra (benralizumab) is approved as an add-on maintenance treatment for eosinophilic asthma, while another IL-5 inhibitor from GlaxoSmithKline’s IL-5
Novartis strengthens case for its combination asthma drug

as AstraZeneca’s asthma injection Fasenra(benralizumab).
Nucala works in rare inflammatory disease, says GSK

GSK is trying to keep the first-to-market IL-5 inhibitor ahead of other drugs in the class, particularly AstraZeneca’s Fasenra (benralizumab) which is gaining ground fast with
AZ reports growth again in Q3, driven by oncology and China sales

AZ’s respiratory franchise also grew 18% to $1.3bn – although the company saw a 4% decline in sales of Symbicort, this was offset by the growth of Pulmicort and Fasenra,
Tecentriq’s triple negative breast cancer use among key CHMP nods

The company also received a positive opinion for a new self-administration option for Fasenra (benralizumab) via a pre-filled, single-use auto-injector, rivalling similar moves from GSK and its

More from news
Approximately 7 fully matching, plus 19 partially matching documents found.

The long and winding road to asthma breakthroughs

But GSK is not alone in the IL-5 inhibitor arena. AstraZeneca’s Fasenra is making waves with its eight-week dosing schedule and $296m in first-half sales – a 244%
AstraZeneca: building a new ‘open innovation’ pharma company

AstraZeneca launched five significant new medicines in 2017: immunotherapy Iminzi, Calquence for mantle cell lymphoma, Qtern in type 2 diabetes, Bevespi Aerosphere in COPD and Fasenra for severe asthma.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Since joining MedImmune in 2006, Bahija has overseen the development of several new medicines, including Imfinzi, Fasenra, Lumoxiti, Siliq and FluMist Quadrivalent.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Client Services Director, Patient Engagement & Solutions, Lo...: Highly competitive salary

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

FREELANCE (Outside IR35) Opportunities for this week below!!!: Superb Day Rate

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Account Director, Publications, Opthalmology, Medical Communicat...: Highly competitive salary

Medical Writer, Women’s health, Medical Communications agency, h...: Highly competitive salary

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Group Account Director, Patient Engagement & Solutions, Lond...: Highly competitive salary

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Senior Account Director, Publications, Opthalmology, Medical Com...: Highly competitive salary

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Senior Medical Writer, Rare diseases, Medical Communications age...: Highly competitive salary

Senior Account Director, Publications, Women’s health, Medical C...: Highly competitive salary

Add my company

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Numbers, navigation, and narratives: digital storytelling in medical communications: Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?: Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed: By Henry Skinner, Chief Executive Officer of the AMR Action Fund...

Email:
Password: